Studies done five years ago when Pfizer's Celebrex and Merck &amp; Co.'s Vioxx were approved suggest the same mechanism that inhibits inflammation and makes them easier on the stomach than traditional painkillers also blocks a substance that prevents heart problems, according to Dr. Garret FitzGerald, chairman of pharmacology at the University of Pennsylvania.
